Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2009 - 2026)

Idexx Laboratories' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $37.7 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 10.63% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $148.8 million (up 10.97% YoY), while the FY2025 annual figure was $145.2 million, up 11.73% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $37.7 million, down from $38.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $38.7 million in Q4 2025, with the low at $26.5 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $29.9 million (2024), against an average of $31.7 million.
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) fell 0.95% in 2023, then increased 17.76% in 2024.
• Idexx Laboratories' Depreciation & Amortization (CF) stood at $28.7 million in 2022, then rose by 3.54% to $29.7 million in 2023, then grew by 13.35% to $33.7 million in 2024, then advanced by 14.88% to $38.7 million in 2025, then declined by 2.68% to $37.7 million in 2026.
• Business Quant data shows IDXX's Depreciation & Amortization (CF) at $37.7 million in Q1 2026, $38.7 million in Q4 2025, and $36.6 million in Q3 2025.